Evidence map›Paper›PMID 27175010›Full record

ArticleMolecular pain2016

Inefficient constitutive inhibition of P2X3 receptors by brain natriuretic peptide system contributes to sensitization of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine.

Anna Marchenkova, Sandra Vilotti, Niels Ntamati, Arn Mjm van den Maagdenberg, Andrea Nistri

Open access · goldAbstract read
In one paragraph

Article in Molecular pain, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. The interictal transcriptomic map of migraine without aura.The journal of headache and pain · 2025
    Article
  3. Review
  4. Overexpressed NaFrontiers in cellular neuroscience · 2021
    Article
  5. Review
  6. Genetic mouse models of migraine.The journal of headache and pain · 2019
    Review
  7. Article
  8. Article
  9. P2X receptor channels in chronic pain pathways.British journal of pharmacology · 2018
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Anna MarchenkovaNeuroscience Department, International School for Advanced Studies (SISSA), Trieste, Italy.
Sandra VilottiNeuroscience Department, International School for Advanced Studies (SISSA), Trieste, Italy.
Niels NtamatiNeuroscience Department, International School for Advanced Studies (SISSA), Trieste, Italy.
Arn Mjm van den MaagdenbergDepartment of Neurology, Leiden University Medical Centre, Leiden, the Netherlands Department of Human Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
Andrea NistriNeuroscience Department, International School for Advanced Studies (SISSA), Trieste, Italy nistri@sissa.it.
Scuola Internazionale Superiore di Studi Avanzati · ITLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOn trigeminal ganglion neurons, pain-sensing P2X3 receptors are constitutively inhibited by brain natriuretic peptide via its natriuretic peptide receptor-A. This inhibition is associated with increased P2X3 serine phosphorylation and receptor redistribution to non-lipid raft membrane compartments. The natriuretic peptide receptor-A antagonist anantin reverses these effects. We studied whether P2X3 inhibition is dysfunctional in a genetic familial hemiplegic migraine type-1 model produced by introduction of the human pathogenic R192Q missense mutation into the mouse CACNA1A gene (knock-in phenotype). This model faithfully replicates several properties of familial hemiplegic migraine type-1, with gain-of-function of CaV2.1 Ca(2+) channels, raised levels of the algogenic peptide calcitonin gene-related peptide, and enhanced activity of P2X3 receptors in trigeminal ganglia.

resultsIn knock-in neurons, anantin did not affect P2X3 receptor activity, membrane distribution, or serine phosphorylation level, implying ineffective inhibition by the constitutive brain natriuretic peptide/natriuretic peptide receptor-A pathway. However, expression and functional properties of this pathway remained intact together with its ability to downregulate TRPV1 channels. Reversing the familial hemiplegic migraine type-1 phenotype with the CaV2.1-specific antagonist, ω-agatoxin IVA restored P2X3 activity to wild-type level and enabled the potentiating effects of anantin again. After blocking calcitonin gene-related peptide receptors, P2X3 receptors exhibited wild-type properties and were again potentiated by anantin.

conclusionsP2X3 receptors on mouse trigeminal ganglion neurons are subjected to contrasting modulation by inhibitory brain natriuretic peptide and facilitatory calcitonin gene-related peptide that both operate via complex intracellular signaling. In the familial hemiplegic migraine type-1 migraine model, the action of calcitonin gene-related peptide appears to prevail over brain natriuretic peptide, thus suggesting that peripheral inhibition of P2X3 receptors becomes insufficient and contributes to trigeminal pain sensitization.

Indexed as

AnimalsCalcitonin Gene-Related Peptide Receptor AntagonistsDisease Models, AnimalGene Knock-In TechniquesMiceMigraine with AuraModels, BiologicalNatriuretic Peptide, Brainomega-Agatoxin IVAPeptides, CyclicPhenotypePurinergic P2X Receptor AntagonistsReceptors, Atrial Natriuretic FactorReceptors, Calcitonin Gene-Related PeptideReceptors, Purinergic P2X3Sensory Receptor Cellsanantinatrial natriuretic factor receptor ACalcitonin Gene-Related Peptide Receptor AntagonistsNatriuretic Peptide, Brainomega-Agatoxin IVAPeptides, CyclicPurinergic P2X Receptor AntagonistsReceptors, Atrial Natriuretic FactorReceptors, Calcitonin Gene-Related PeptideReceptors, Purinergic P2X3TRPV1 protein, mouseTRPV Cation Channelsadenosine triphosphate (ATP)calcitonin gene-related peptidefamilial hemiplegic migraine type-1lipid raftnociceptionpurinergic receptorTrigeminal ganglia

Identifiers

PMID27175010
PMCPMC4955999
OpenAlexW2364870236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.